The long-term impact of surgical complications after resection of stage i nonsmall cell lung cancer: A population-based survival analysis

Annals of Surgery

Volumn 254, Issue 2, 2011, Pages 368-374

  Rueth, Natasha M ^a   Parsons, Helen M ^b   Habermann, Elizabeth B ^a   Groth, Shawn S ^a   Virnig, Beth A ^b,c   Tuttle, Todd M ^a,c   Andrade, Rafael S ^a   Maddaus, Michael A ^a,c   D'Cunha, Jonathan ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; KAPLAN MEIER METHOD; KIDNEY DISEASE; LIVER DISEASE; LOBECTOMY; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; NONPNEUMONIA INFECTIOUS DISEASE; OVERALL SURVIVAL; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME; TUMOR VOLUME; WOUND COMPLICATION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES;

EID: 80955177200     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822150fe     Document Type: Article

References (29)

1. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81(3):1013-1019; discussion 1019-1020.
2. Boffa DJ, Allen MS, Grab JD, et al. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135(2):247-254.
3. Rueth NM, Andrade RS. Is VATS lobectomy better: perioperatively, biologically and oncologically? Ann Thorac Surg. 2010;89(6):S2107-S2111.
4. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345(3):181-188. (Pubitemid 32662128)
5. Bilimoria KY, Talamonti MS, Sener SF, et al. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008;207(4):510-519.
6. Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol. 2003;83(2):68-78; discussion 78-79. (Pubitemid 36667413)
7. Verhoef C, van de Weyer R, Schaapveld M, et al. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol. 2007;14(5):1678-1687. (Pubitemid 46791010)
8. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER Database: Incidence-SEER Regs Public-Use November 2007. Washington, DC: National Cancer Institute.
9. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-IV-18.
10. American Joint Committee on Cancer: Cancer Staging Handbook from the AJCC Cancer Staging Manual; www.cancerstaging.org, Springer, 2002.
11. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. http://www.nccn.org.
12. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615-622; discussion 622-623.
13. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19, 702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer. 2007;110(7):1532-1541. (Pubitemid 47463068)
14. Flores RM, Park BJ, Dycoco J, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 2009;138(1):11-18.
15. Yang X, Wang S, Qu J. Video-assisted thoracic surgery (VATS) compares favorably with thoracotomy for the treatment of lung cancer: a five-year outcome comparison. World J Surg. 2009;33(9):1857-1861.
16. Yu Greenblatt D, Weber SM, O'Connor ES, et al. Readmission After Colectomy for Cancer Predicts One-Year Mortality. Ann Surg. 2010;251(4):659-669.
17. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418-1428.
18. Blumberg N, Heal J, Chuang C, et al. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg. 1988;207(4):410-415.
19. Schipper PH, Diggs BS, Ungerleider RM, Welke KF. The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg. 2009;88(5):1566-1572; discussion 1572-1573.
20. Klabunde CN, Legler JM, Warren JL, et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590. (Pubitemid 47096709)
21. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2005;28(5):759-762. (Pubitemid 41539333)
22. Bramer S, van Straten AH, Soliman Hamad MA, et al. The impact of newonset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg. 2010;90(2):443-449.
23. Filardo G, Hamilton C, Hamman B, et al. New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann Thorac Surg. 2010;90(2):474-479.
24. Kirby TJ, Mack MJ, Landreneau RJ, Rice TW. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg. 1995;109(5):997-1001; discussion 1001-1002.
25. Whitson BA, Andrade RS, Boettcher A, et al. Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007;83(6):1965-1970. (Pubitemid 46782660)
26. Whitson BA, D'Cunha J, Andrade RS, et al. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity. Ann Thorac Surg. 2008;86(6):1735-1744.
27. Vogel TR, Dombrovskiy VY, Lowry SF. In-hospital delay of elective surgery for high volume procedures: the impact on infectious complications. J Am Coll Surg. 2010;211(6):784-790.
28. Zaydfudim V, Dossett LA, Starmer JM, et al. Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg. 2009;144(7):656-662.
29. Carless PA, Henry DA, Carson JL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2010; (10): CD002042.